Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.05
Delayed Data
As of Aug 16
 0.00 / 0.00%
Today’s Change
0.92
Today|||52-Week Range
1.82
-16.67%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.05
Today’s open1.05
Day’s range1.04 - 1.09
Volume17,772
Average volume (3 months)123,335
Market cap$74.7M
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-31.82%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-58.10%
P/E ratioNM
Price/Sales18.65
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...+0.01+1.15%
CEMIChembio Diagnostics ...+0.05+0.82%
MRNSMarinus Pharmaceutic...+0.14+4.91%
ARLZAralez Pharmaceutica...+0.01+0.93%
Data as of 08/16/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.7M
Annual profit (last year)-$22.7M
Net profit margin-482.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, Chief Operating Officer &
Secretary
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts